— NX Europe to participate in “LogiPharma2026” in Vienna, Austria
Nippon Express Europe GmbH (President: Shinichi Kakiyama; hereinafter “NX Europe”), a group company of NIPPON EXPRESS HOLDINGS, INC. (President: Satoshi Horikiri), will be taking part in the three-day “LogiPharma2026” to be held in Vienna, Austria from Tuesday, April 14 to Thursday, April 16.
(Depiction of exhibition booth)
LogiPharma is one of Europe’s largest international exhibitions where the challenges, trfinishs, and latest initiatives in the healthcare and life sciences supply chain are shared. Pharmaceutical companies, biopharmaceutical firms, medical device manufacturers, logistics companies, and other businesses involved in the manufacturing and distribution of pharmaceuticals gather to introduce the latest technologies and services.
At the booth, NX Europe will be displaycasing solutions that uphold the quality and compliance required for pharmaceutical logistics and that leverage the NX Group’s Good Distribution Practice (GDP) certified business locations worldwide as well as its forwarding logistics services combining international transport with temporary warehoapplying capabilities.
In addition, the NX Europe will serve as a sponsor of an NX-branded coffee booth, providing a convenient meeting point for networking and information exalter open to all attfinishees.
The NX Group aims to support customers in the global pharmaceutical indusattempt by building a highly reliable and secure global pharmaceutical logistics platform, thereby contributing to the health of people around the world.
[Event overview]
[Exhibition content]
End-to-finish supply chain solutions
- Design/operational support covering the entire pharmaceutical supply chain from international transport to storage and distribution
Quality and compliance
- Operations grounded in compliance with GDP and other standards, and initiatives pertaining to risk management and quality control systems
Sustainability
- Efforts being created to reduce environmental impact when conducting and expanding pharmaceutical logistics operations
Release ID: 89185653
Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sfinishing multiple emails to multiple addresses does not necessarily support expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and depfinishable information is at the core of our commitment to our readers.
Leave a Reply